Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
All content for Fenben® Voices is the property of Fenbendazole Help and is served directly from their servers
with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
S1EP13 Pressing Forward: The Peer-Reviewed Path of Fenbendazole in Cancer Research
Fenben® Voices
4 minutes
11 months ago
S1EP13 Pressing Forward: The Peer-Reviewed Path of Fenbendazole in Cancer Research
Got Questions? Send us a message!Join us on "Fenben Voices" to uncover "Pressing Forward: The Peer-Reviewed Path of Fenbendazole in Cancer Research." We unravel a new study that highlights the combined use of fenbendazole with other antiparasitics in cancer treatment. This episode examines the rigorous research backing and the broader implications for oncology. Listen as we explore:Overview of Recent Study: Details of the peer-reviewed research combining fenbendazole with ivermectin and meben...
Fenben® Voices
Got Questions? Send us a message! We explore whether two old antiparasitics, fenbendazole and ivermectin, can meaningfully impact cancer by disrupting cell structure, metabolism, and immune signaling while challenging how drugs get approved and funded. We lay out the science, question the incentives, and call for trials that prioritize survival and quality of life. • Fenbendazole as a microtubule destabilizer leading to cell‑cycle arrest and apoptosis • Potential to bypass efflux pump resist...
